While some desperate hospitals have set up parking lot compounding shops to help with drug sourcing, a group of health care providers is taking a more substantial approach, teaming up to manufacture and sell generic drugs at cheaper prices than industry firms have been doing. In a Jan. 18 announcement, Intermountain Health Care Inc., Ascension, SSM Health and Trinity Health said they will form their own non-profit generic drug maker to address shortages and price hikes that have plagued hospitals and patients.
Provider Consortium Will Try 'DIY' Solution To Generic Shortages, Pricing
Four health care systems representing 280 hospitals, with input from the US Department of Veterans Affairs, plan to make and sell their own generic drugs, focusing on those vitally needed by hospitals, with "appropriate" pricing.
More from Drug Pricing
More from Scrip
• By
Arbele has emerged as a global leader in the Cadherin 17 area, not only in clinical progress but also for its “secret recipe” for application in T-cell engagers, its CEO tells Scrip.
• By
Roivant president Eric Venker was named CEO of Immunovant to guarantee execution of the development plan for IMVT-1402 in six indications, now including Sjögren’s disease and cutaneous lupus erythematosus.
• By
As investors have begun to ask troubled drug developers to suspend operations and return remaining cash to shareholders, Alis has stepped forward with a new fund aiming to facilitate that.